43 research outputs found

    Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies

    Get PDF
    Circulating tumor cells (CTCs) have been exclusively studied and served to assess the clinical outcomes of treatments and progression of cancer. Most CTC data have mainly been derived from distinct cohorts or selected tumor types. In the present study, a total of 594 blood samples from 479 cases with 19 different carcinomas and 30 healthy samples were collected and analyzed by Subtraction enrichment method combined with immunostaining-fluorescence in situ hybridization (iFISH). Non-hematopoietic cells with aneuploid chromosome 8 (more than 2 copies) were regarded as positive CTCs. The results showed that none of CTCs was found in all 30 healthy samples. The overall positive rate of CTCs was 89.0% in diagnosed cancer patients (ranging from 75.0% to 100.0%). Average number of 11, 5, 8 and 4 CTCs per 7.5 mL was observed in lung cancer, liver cancer, renal cancer and colorectal cancer, respectively. Among 19 different carcinomas, the total number of CTCs, tetraploid chromosome 8, polyploid chromosome 8, CTM (Circulating tumor microemboli) and large CTCs in patients with stage Ⅲ and Ⅳ were statistically higher than patients with stage Ⅰ and Ⅱ (P < 0.05). Furthermore, EpCAM expression was more frequently found in most CTCs than vimentin expression, confirming that these CTCs were of epithelial origin. In addition, small and large CTCs were also classified, and the expression of vimentin was mostly observed in small CTCs and CTM. Our results revealed that there are higher numbers of CTCs, tetraploid, polyploid and large CTCs in patients with stage Ⅲ and Ⅳ, indicating that the quantification of chromosome ploidy performed by SE-iFISH for CTCs might be a useful tool to predict and evaluate therapeutic efficacy as well as to monitoring disease progression

    Prevalence of sexual dysfunction and its association with psychological symptoms in drug-naive major depressive disorder patients in West China

    Get PDF
    BackgroundSexual dysfunction is commonly observed in individuals with Major Depressive Disorder (MDD), along with various psychological symptoms such as anxiety, somatic complaints, interpersonal sensitivity, and obsessive-compulsive tendencies. However, there is a research gap in understanding the impact of these psychological symptoms on sexual functioning in MDD. Furthermore, there is limited data on the incidence of sexual dysfunction among drug-naive MDD patients in West China. This study aims to determine the prevalence of sexual dysfunction in this patient population and explore its association with other psychological indicators.MethodsWe conducted a retrospective analysis of patient data from October 2020 to September 2022 using propensity score matching. A focused group of 165 males and 490 females was selected from a total of 1941 MDD patients. This allowed for a comparative analysis of demographic data, as well as scores from the Self-Rating Depression Scale (SDS), Self-Rating Anxiety Scale (SAS), and Symptom Checklist-90 (SCL-90), the Arizona Sexual Experience Scale (ASEX).ResultsOur findings reveal that 46.2% of drug-naive MDD patients experienced sexual dysfunction. Notably, there was a higher prevalence of sexual dysfunction among female patients (50.3%) compared to males (37.5%). MDD patients without sexual dysfunction consistently exhibited higher SDS scores than those with sexual dysfunction (p &lt; 0.01), There were no statistically significant differences between male and female MDD patients with or without concomitant sexual dysfunction in terms of Somatic complaints, Obsessive-compulsive, Interpersonal sensitivity, Anxiety, Phobic anxiety, Paranoid ideation, Psychoticism and Diet/sleep difficulties (p &gt; 0.05). In addition, male MDD patients with sexual dysfunction showed a emerging trend towards elevated Hostility scores on the SCL-90 (p = 0.058), male MDD patients with sexual dysfunction showed an increasing trend in hostility scores on the SCL-90, whereas female MDD patients with sexual dysfunction did not show such a trend.ConclusionThe study highlights a significant gender difference in the prevalence of sexual dysfunction among MDD patients, with females being more susceptible than males. There is a positive correlation between the severity of depression and sexual dysfunction in both genders. Interestingly, male MDD patients demonstrated a potential protective effect of hostility against sexual dysfunction, which was not observed in female patients

    CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis

    Full text link
    BACKGROUND: To systematically investigate the relationship between CT morphological features and the presence of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC). METHODS: All studies about the CT morphological features of NSCLC with EGFR mutations published between January 1, 2000 and March 15, 2015 were searched in the PubMed and EMBASE databases. Qualified studies were selected according to inclusion criteria. The frequency of EGFR mutations and CT features of ground-glass opacity (GGO) content, tumor size, cavitation, air-bronchogram, lobulation, and spiculation were extracted. The relationship between EGFR mutations and each of these CT features was tested based upon the weighted mean difference or inverse variance in the form of an odds ratio at a 95% confidence interval using Forest Plots. The publication bias was examined using Egger’s test. RESULTS: A total of 13 studies, consisting of 2146 NSCLC patients, were included, and 51.12% (1097/2146) of patients had EGFR mutations. The EGFR mutations were present in NSCLC with part-solid GGO in contrast to nonsolid GGO (OR = 0.49, 95% CI = 0.25–0.96, P = 0.04). Other CT features such as tumor size, cavitation, air-bronchogram, lobulation and spiculation did not demonstrate statistically significant correlation with EGFR mutations individually (P = 0.91; 0.67; 0.12; 0.45; and 0.36, respectively). No publication bias among the selected studies was noted in this meta-analysis (Egger’s tests, P > 0.05 for all). CONCLUSION: This meta-analysis demonstrated that NSCLC with CT morphological features of part-solid GGO tended to be EGFR mutated, which might provide an important clue for the correct selection of patients treated with molecular targeted therapies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12880-016-0175-3) contains supplementary material, which is available to authorized users

    CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis

    No full text
    Abstract Background To systematically investigate the relationship between CT morphological features and the presence of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC). Methods All studies about the CT morphological features of NSCLC with EGFR mutations published between January 1, 2000 and March 15, 2015 were searched in the PubMed and EMBASE databases. Qualified studies were selected according to inclusion criteria. The frequency of EGFR mutations and CT features of ground-glass opacity (GGO) content, tumor size, cavitation, air-bronchogram, lobulation, and spiculation were extracted. The relationship between EGFR mutations and each of these CT features was tested based upon the weighted mean difference or inverse variance in the form of an odds ratio at a 95% confidence interval using Forest Plots. The publication bias was examined using Egger’s test. Results A total of 13 studies, consisting of 2146 NSCLC patients, were included, and 51.12% (1097/2146) of patients had EGFR mutations. The EGFR mutations were present in NSCLC with part-solid GGO in contrast to nonsolid GGO (OR = 0.49, 95% CI = 0.25–0.96, P = 0.04). Other CT features such as tumor size, cavitation, air-bronchogram, lobulation and spiculation did not demonstrate statistically significant correlation with EGFR mutations individually (P = 0.91; 0.67; 0.12; 0.45; and 0.36, respectively). No publication bias among the selected studies was noted in this meta-analysis (Egger’s tests, P > 0.05 for all). Conclusion This meta-analysis demonstrated that NSCLC with CT morphological features of part-solid GGO tended to be EGFR mutated, which might provide an important clue for the correct selection of patients treated with molecular targeted therapies

    Simulation study on creep deformation of the impeller in lead-bismuth eutectic environment through fluid-solid coupling method

    No full text
    Lead-based reactor is a new type of reactor using liquid lead or lead-bismuth alloy as a coolant. As the core working element of the main pump, the impeller is subjected to a huge load when conveying heavy metal liquids and is highly susceptible to damage. In this study, we used ANSYS and FLUENT software to investigate the stress, deformation, and creep deformation of the nuclear main pump impeller under a liquid lead-bismuth environment by the fluid-solid coupling method. The maximum equivalent force of the impeller was located at the junction of the blade and hub, which was prone to fatigue damage under the action of alternating load. The stress, deformation, and creep characteristics of the impeller blade were observed to generally increase with rotational speed. Particularly, the junction of the blade root and hub exhibited high susceptibility to stress concentration and fatigue damage. At a flow rate of 0.64 m/s and a speed of 690 r/min, the maximum equivalent force was 16.7 MPa, which was lower than the yield strength of 316L stainless steel. Additionally, the maximum deformation was less than 0.63 mm. Over a five-year period, the creep of the impeller ranged from a minimum of 0.228% to a maximum of 0.447%, indicating that the impeller can reliably operate in a liquid lead-bismuth environment for at least five years

    The polymer composite electrolyte with polyethylene oxide-grafted graphene oxide as fillers toward stable highcurrent density lithium metal anodes

    No full text
    Adding inorganic fillers to polymer electrolytes is one of the main means to improve ionic conductivity. However, the filler will aggregate, causing the problem of incompatibility between the electrolyte and the metal lithium negative electrode. According to reports, the flaky structure of graphene oxide (GO) has the characteristics of large specific surface area and stable performance, which has attracted widespread attention as a filler for polymer electrolytes. However, the electrolyte membrane has poor compatibility with lithium negative electrodes when GO as a filler, which is not conducive to the full performance of lithium batteries. In this paper, we grafted polyethylene oxide (PEO) on the surface of GO (the product is referred to as GO@PEO) to improving the dispersibility of the filler and the compatibility of the gel polymer electrolyte (GPE) with lithium metal . It is worth that after GO grafting PEO, the impedance of the interface between GPE and lithium metal is significantly reduced, and the compatibility of the electrolyte with the lithium negative electrode is significantly improved. Assembled into Li/ Li battery, the surface current cycle is stable, up to 1 mA cm ^−2 . GO@PEO further improves the ionic conductivity of the ion conductivity up to 1.6 mS cm ^−1 . Further prepared into LiFePO _4 (LFP)/Li battery, GPE-GO@PEO showed excellent cycle stability and the discharge specific capacity retention rate was 95.6% after 100 cycles. The rate performance of the battery is also significantly improved. At 5C, the discharge specific capacity of the LFP/Li battery remains 40 mAh g ^−1
    corecore